Nicolas Skrypek

1.0k total citations
13 papers, 815 citations indexed

About

Nicolas Skrypek is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Nicolas Skrypek has authored 13 papers receiving a total of 815 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Oncology and 3 papers in Surgery. Recurrent topics in Nicolas Skrypek's work include Pancreatic and Hepatic Oncology Research (5 papers), Glycosylation and Glycoproteins Research (5 papers) and Epigenetics and DNA Methylation (4 papers). Nicolas Skrypek is often cited by papers focused on Pancreatic and Hepatic Oncology Research (5 papers), Glycosylation and Glycoproteins Research (5 papers) and Epigenetics and DNA Methylation (4 papers). Nicolas Skrypek collaborates with scholars based in France, United States and Belgium. Nicolas Skrypek's co-authors include Isabelle Van Seuningen, Nicolas Jonckheere, Geert Berx, Steven Goossens, Niels Vandamme, Eva De Smedt, Bélinda Duchêne, Emmanuelle Leteurtre, Mohamed Hebbar and Bieke Soen and has published in prestigious journals such as The Journal of Experimental Medicine, PLoS ONE and Cancer Research.

In The Last Decade

Nicolas Skrypek

13 papers receiving 807 citations

Peers

Countries citing papers authored by Nicolas Skrypek

Since Specialization

Citations

This map shows the geographic impact of Nicolas Skrypek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Skrypek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Skrypek more than expected).

Fields of papers citing papers by Nicolas Skrypek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Skrypek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Skrypek. The network helps show where Nicolas Skrypek may publish in the future.

Co-authorship network of co-authors of Nicolas Skrypek

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Skrypek. A scholar is included among the top collaborators of Nicolas Skrypek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Skrypek. Nicolas Skrypek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	DNA Methyltransferase 3B–Mediated Intratumoral Heterogeneity and Therapeutic Targeting in Breast Cancer Recurrence and Metastasis 2022 ·Molecular Cancer Research ·Jae Young So, Howard H. Yang, (unknown), Nicolas Skrypek, Hiroki Ishii, (unknown), Maxwell P. Lee, Yang Li	8
2	The EGF Domains of MUC4 Oncomucin Mediate HER2 Binding Affinity and Promote Pancreatic Cancer Cell Tumorigenesis 2021 ·Cancers ·(unknown), (unknown), Céline Schulz, (unknown), (unknown), Romain Magnez, (unknown), Nicolas Skrypek, (unknown), Frédéric Frénois, Xavier Thuru, Patricia Melnyk, Nicolas Renault, Nicolas Jonckheere, Nicolas Lebègue, Isabelle Van Seuningen	7
3	Induction of DNMT3B by PGE2 and IL6 at Distant Metastatic Sites Promotes Epigenetic Modification and Breast Cancer Colonization 2020 ·Cancer Research ·Jae Young So, Nicolas Skrypek, Howard H. Yang, Anand S. Merchant, George W. Nelson, Wei-Dong Chen, Hiroki Ishii, (unknown), Gangqing Hu, Bhagelu R. Achyut, Esther Yoon, Liying Han, Chuanshu Huang, Margaret C. Cam, Keji Zhao, Maxwell P. Lee, Li Yang	40
4	ZEB2 stably represses RAB25 expression through epigenetic regulation by SIRT1 and DNMTs during epithelial-to-mesenchymal transition 2018 ·Epigenetics & Chromatin ·Nicolas Skrypek, (unknown), (unknown), Eva De Smedt, Bieke Soen, (unknown), Joachim Taminau, Steven Goossens, Niels Vandamme, Geert Berx	15
5	Epithelial-to-Mesenchymal Transition: Epigenetic Reprogramming Driving Cellular Plasticity 2017 ·Trends in Genetics ·Nicolas Skrypek, Steven Goossens, Eva De Smedt, Niels Vandamme, Geert Berx	192
6	The transcription factor Zeb2 regulates development of conventional and plasmacytoid DCs by repressing Id2 2016 ·The Journal of Experimental Medicine ·Charlotte L. Scott, Bieke Soen, Liesbet Martens, Nicolas Skrypek, Wouter Saelens, Joachim Taminau, Gillian Blancke, Gert Van Isterdael, Danny Huylebroeck, Jody J. Haigh, Yvan Saeys, Martin Guilliams, Bart N. Lambrecht, Geert Berx	108
7	Overexpression of chemokine receptor CXCR2 and ligand CXCL7 in liver metastases from colon cancer is correlated to shorter disease‐free and overall survival 2015 ·Cancer Science ·Thibault Desurmont, Nicolas Skrypek, Alain Duhamel, Nicolas Jonckheere, Guillaume Y. Millet, Emmanuelle Leteurtre, Philippe Gosset, Bélinda Duchêne, Nassima Ramdane, Mohamed Hebbar, Isabelle Van Seuningen, François‐René Pruvot, Guillemette Huet, Stéphanie Truant	59
8	The mucin MUC4 is a transcriptional and post-transcriptional target of K-ras oncogene in pancreatic cancer. Implication of MAPK/AP-1, NF-κB and RalB signaling pathways 2015 ·Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms ·(unknown), Nicolas Skrypek, Bélinda Duchêne, Florence Renaud, Daniel Martínez‐Maqueda, Audrey Vincent, Nicole Porchet, Isabelle Van Seuningen, Nicolas Jonckheere	25
9	The oncogenic receptor ErbB2 modulates gemcitabine and irinotecan/SN-38 chemoresistance of human pancreatic cancer cells via hCNT1 transporter and multidrug-resistance associated protein MRP-2 2015 ·Oncotarget ·Nicolas Skrypek, (unknown), Audrey Vincent, Bélinda Duchêne, Isabelle Van Seuningen, Nicolas Jonckheere	37
10	Mucins and tumor resistance to chemotherapeutic drugs 2014 ·Biochimica et Biophysica Acta (BBA) - Reviews on Cancer ·Nicolas Jonckheere, Nicolas Skrypek, Isabelle Van Seuningen	80
11	The MUC4 mucin mediates gemcitabine resistance of human pancreatic cancer cells via the Concentrative Nucleoside Transporter family 2012 ·Oncogene ·Nicolas Skrypek, Bélinda Duchêne, Mohamed Hebbar, Emmanuelle Leteurtre, Isabelle Van Seuningen, Nicolas Jonckheere	124
12	The Mucin MUC4 and Its Membrane Partner ErbB2 Regulate Biological Properties of Human CAPAN-2 Pancreatic Cancer Cells via Different Signalling Pathways 2012 ·PLoS ONE ·Nicolas Jonckheere, Nicolas Skrypek, (unknown), Anne‐Frédérique Dessein, Patrick Dumont, Emmanuelle Leteurtre, Ann Harris, Jean‐Luc Desseyn, Christiane Susini, Frédéric Frénois, Isabelle Van Seuningen	44
13	Mucins and Pancreatic Cancer 2010 ·Cancers ·Nicolas Jonckheere, Nicolas Skrypek, Isabelle Van Seuningen	76

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact